TY - JOUR
T1 - Multi-targeting oligopyridiniums: Rational design for biofilm dispersion and bacterial persister eradication
AU - Li, Jiaqi
AU - Yu, Yue
AU - Zhou, Yu
AU - Song, Junfeng
AU - Yang, Anming
AU - Wang, Min
AU - Li, Youzhi
AU - Wan, Muyang
AU - Zhang, Chunhui
AU - Yang, Huan
AU - Bai, Yugang
AU - Wong, Wing Leung
AU - Pu, Huangsheng
AU - Feng, Xinxin
N1 - Publisher Copyright:
© 2024 Elsevier Inc.
PY - 2024/3
Y1 - 2024/3
N2 - The development of effective antibacterial drugs to combat bacterial infections, particularly the biofilm-related infections, remains a challenge. There are two important features of bacterial biofilms, which are well-known critical factors causing biofilms hard-to-treat in clinical, including the dense and impermeable extracellular polymeric substances (EPS) and the metabolically repressed dormant and persistent bacterial population embedded. These characteristics largely increase the difficulty for regular antibiotic treatment due to insufficient penetration into EPS. In addition, the dormant bacteria are insensitive to the growth-inhibiting mechanism of traditional antibiotics. Herein, we explore the potential of a series of new oligopyridinium-based oligomers bearing a multi-biomacromolecule targeting function as the potent bacterial biofilm eradication agent. These oligomers were rationally designed to be “charge-on-backbone” that can offer a special alternating amphiphilicity. This novel and unique feature endows high affinity to bacterial membrane lipids, DNAs as well as proteins. Such a broad multi-targeting nature of molecules not only enables its penetration into EPS, but also plays vital roles in the bactericidal mechanism of action that is highly effective against dormant and persistent bacteria. Our in vitro, ex vivo, and in vivo studies demonstrated that OPc3, one of the most effective derivatives, was able to offer excellent antibacterial potency against a variety of bacteria and effectively eliminate biofilms in zebrafish models and mouse wound biofilm infection models.
AB - The development of effective antibacterial drugs to combat bacterial infections, particularly the biofilm-related infections, remains a challenge. There are two important features of bacterial biofilms, which are well-known critical factors causing biofilms hard-to-treat in clinical, including the dense and impermeable extracellular polymeric substances (EPS) and the metabolically repressed dormant and persistent bacterial population embedded. These characteristics largely increase the difficulty for regular antibiotic treatment due to insufficient penetration into EPS. In addition, the dormant bacteria are insensitive to the growth-inhibiting mechanism of traditional antibiotics. Herein, we explore the potential of a series of new oligopyridinium-based oligomers bearing a multi-biomacromolecule targeting function as the potent bacterial biofilm eradication agent. These oligomers were rationally designed to be “charge-on-backbone” that can offer a special alternating amphiphilicity. This novel and unique feature endows high affinity to bacterial membrane lipids, DNAs as well as proteins. Such a broad multi-targeting nature of molecules not only enables its penetration into EPS, but also plays vital roles in the bactericidal mechanism of action that is highly effective against dormant and persistent bacteria. Our in vitro, ex vivo, and in vivo studies demonstrated that OPc3, one of the most effective derivatives, was able to offer excellent antibacterial potency against a variety of bacteria and effectively eliminate biofilms in zebrafish models and mouse wound biofilm infection models.
KW - Bacterial biolfilm
KW - Bacterial persisters
KW - Extracellular polymeric substances
KW - Multi-targeting
KW - Oligopyridiniums
UR - http://www.scopus.com/inward/record.url?scp=85184032869&partnerID=8YFLogxK
U2 - 10.1016/j.bioorg.2024.107163
DO - 10.1016/j.bioorg.2024.107163
M3 - Journal article
C2 - 38306825
AN - SCOPUS:85184032869
SN - 0045-2068
VL - 144
JO - Bioorganic Chemistry
JF - Bioorganic Chemistry
M1 - 107163
ER -